Add Yahoo as a preferred source to see more of our stories on Google. Ozempic, pictured in May 2022, contains semaglutide, which is used to treat diabetes and obesity. Health Canada says it is ...

HTA Methods Guide – On November 28, 2024, Canada’s Drug Agency (CDA) launched a consultation on its first-ever methods guide. The consultation seeks stakeholder input to enhance the methods guide, ...

Health Canada is warning people not to buy or use fake or unauthorized versions of GLP-1 drugs such as semaglutide, the ...

On September 18, 2025, Canada’s Drug Agency (CDA) launched its new strategy to improve the appropriate prescribing and use of prescription medications in Canada. The strategy, titled “A Prescription ...

CHARLOTTETOWN, PE, March 7, 2025 /CNW/ - No one should have to choose between paying for prescription drugs and putting food on the table. That's why the Government of Canada is taking action so ...

VICTORIA, British Columbia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The power of social media for marketing products to viewers who make purchasing decisions based on their interaction with apps is ...

An article appearing in the Canadian Journal of Cardiology exposes the complexities of the Canadian drug review process and makes a case for a unified framework to improve the present infrastructure, ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer cheaper generic versions of medications like Ozempic and Wegovy to people with ...

Having generics that might significantly reduce the price is welcome, obesity physician says. Health Canada says it is reviewing nine submissions (new window) for generic versions of popular weight ...